FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, May 20, 2026
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on May 20, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 9cf9322f-a3eb-487f-b14c-efa66760f778
Inspection Facts
- Inspection number
- 1318208
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Merck Sharp & Dohme LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2024 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 16, 2021 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| October 30, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 21, 2016 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 24, 2014 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1230849 - 2024-06-12
- FDA Inspection 1140222 - 2021-04-16
- FDA Inspection 1070336 - 2018-10-30
- FDA Inspection 998099 - 2016-11-21
- FDA Inspection 903682 - 2014-11-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.